Organoids in Cancer Research and Regenerative Medicine: Current Status, Challenges, and Future Prospects
MedComm · 2026-01 · 7 (1)
DOI: 10.1002/mco2.70575 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 05.01.2026. Verfasst von Ruiyang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 332 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Cancer and tissue regeneration pose great challenges to global health, as cancer treatment is impeded by tumor heterogeneity and therapy resistance, while regenerative medicine is constrained by donor shortages and difficulties in replicating native tissue structures. Organoids, as advanced three‐dimensional multicellular structures derived from stem cells, have emerged as transformative tools in biomedical research. They recapitulate key aspects of native human tissue composition and functions, offering enhanced physiological relevance over traditional models. Therefore, this review aims to highlight the latest advancements in organoid technology within the fields of cancer research and regenerative medicine. We begin by discussing the fundamental aspects of organoid generation, characterization, and application. Furthermore, recent progress in both cancer‐oriented and regeneration‐focused organoids is summarized, with an emphasis on their applications in disease modeling, drug screening, mechanistic analysis, and precision medicine. Based on an extensive review of the literature, the current challenges and future directions in the development and application of organoid models are discussed. As organoid technology continues to evolve, it is anticipated that more high‐quality studies will further advance medical science and foster innovation in personalized therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China.
- MedEng-X Institutes Shanghai University Shanghai China.
- Trauma Orthopedics Center Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China.
- Institute of Musculoskeletal Injury and Translational Medicine of Organoids Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China.
- Institute of Translational Medicine Shanghai University Shanghai China.
- National Center for Translational Medicine SHU Branch Shanghai University Shanghai China.
ORCID-Profile: Jiacan Su
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Li, R., Wu, Y., Zheng, Z., Zhou, F., Xu, K., & Su, J. (2026). Organoids in Cancer Research and Regenerative Medicine: Current Status, Challenges, and Future Prospects. MedComm, 7(1). https://doi.org/10.1002/mco2.70575
Vancouver
Li R, Wu Y, Zheng Z, Zhou F, Xu K, Su J. Organoids in Cancer Research and Regenerative Medicine: Current Status, Challenges, and Future Prospects. MedComm. 2026;7(1). doi:10.1002/mco2.70575
BibTeX
@article{Li2026,
author = {Li, Ruiyang and Wu, Yuezhou and Zheng, Zhu'anzhen and Zhou, Fengjin and Xu, Ke and Su, Jiacan},
title = {Organoids in Cancer Research and Regenerative Medicine: Current Status, Challenges, and Future Prospects},
journal = {MedComm},
year = {2026},
volume = {7},
number = {1},
doi = {10.1002/mco2.70575}
}
EUVIMED